Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Smooth Emergence After Thyroidectomy
NCT02412150Completed
- Sponsor
- Chosun University Hospital
- Start
- Apr 2014
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in thyroid tumor (2 arms), sponsored by Chosun University Hospital. Primary endpoint: Postoperative bleeding at 3 days. Started Apr 2014; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
thyroid tumor
Beyond the preview
Go deeper on NCT02412150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02412150.